In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging

This publication has 10 references indexed in Scilit:

• Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivatization of gadolinium with Arsenazo III
  Journal of Pharmaceutical and Biomedical Analysis, 1995
• Hepato-biliary and renal excretion in mice of charged and neutral gadolinium complexes of cyclic tetra-aza-phosphinic and carboxylic acids
  Magnetic Resonance Imaging, 1993
• Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast Agent
  Investigative Radiology, 1993
• Biodistribution and toxicity of MR imaging contrast media
  Journal of Magnetic Resonance Imaging, 1993
• Dissociation of gadolinium chelates in mice: Relationship to chemical characteristics
  Magnetic Resonance Imaging, 1992
• A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent
  Investigative Radiology, 1991
• Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2−, Gd(DOTA)−, and Gd(acetate)n in mice
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
• Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues
  Magnetic Resonance Imaging, 1987
• Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
  American Journal of Roentgenology, 1984
• Metabolism of the Lanthanons in the Rat.
  Experimental Biology and Medicine, 1956